HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Requirement of NOX2 expression in both retina and bone marrow for diabetes-induced retinal vascular injury.

AbstractOBJECTIVE:
Diabetic retinopathy, a major cause of blindness, is characterized by increased expression of vascular endothelial growth factor (VEGF), leukocyte attachment to the vessel walls and increased vascular permeability. Previous work has shown that reactive oxygen species (ROS) produced by the superoxide generating enzyme NOX2/NADPH oxidase play a crucial role in the vascular pathology. The aim of this work was to identify the cellular sources of the damaging NOX2 activity by studies using bone marrow chimera mice.
METHODS:
Bone marrow cells were collected from the femurs and tibias of wild type and NOX2 deficient (NOX2(-/-)) donor mice and injected intravenously into lethally irradiated NOX2(-/-) and wild type recipients. Following recovery from radiation, mice were rendered diabetic by streptozotocin injections. The following groups of bone marrow chimeras were studied: non-diabetic WT → WT, diabetic WT → WT, diabetic WT → NOX2(-/-), diabetic NOX2(-/-) → WT. After 4 weeks of diabetes, early signs of retinopathy were examined by measuring ROS, expression of VEGF and ICAM-1, leukocyte attachment to the vessel wall and vascular permeability.
RESULTS:
The retinas of the diabetic WT → WT chimeras showed significant increases in ROS as compared with the non-diabetic chimeras. These diabetes-induced alterations were correlated with increases in expression of VEGF and ICAM-1, leukocyte adhesion and vascular permeability. Each of these diabetes-induced alterations were significantly attenuated in the diabetic WT → NOX2(-/-) and NOX2(-/-) → WT chimera groups (p<0.05).
CONCLUSION:
NOX2-generated ROS produced by both bone marrow-derived cells and resident retinal cells contribute importantly to retinal vascular injury in the diabetic retina. Targeting NOX2 in bone marrow and/or retinal cells may represent a novel therapeutic strategy for the treatment/prevention of vascular injury in the diabetic retina.
AuthorsModesto Rojas, Wenbo Zhang, Zhimin Xu, Tahira Lemtalsi, Phillip Chandler, Haroldo A Toque, Robert W Caldwell, Ruth B Caldwell
JournalPloS one (PLoS One) Vol. 8 Issue 12 Pg. e84357 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24358357 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Membrane Glycoproteins
  • Vascular Endothelial Growth Factor A
  • Intercellular Adhesion Molecule-1
  • Peroxynitrous Acid
  • Tyrosine
  • Cybb protein, mouse
  • NADPH Oxidase 2
  • NADPH Oxidases
  • Leukocyte Common Antigens
Topics
  • Animals
  • Blood-Retinal Barrier (metabolism, pathology)
  • Bone Marrow (metabolism)
  • Cell Adhesion
  • Chimera
  • Diabetes Mellitus, Experimental
  • Diabetic Retinopathy (genetics, metabolism, pathology)
  • Gene Expression
  • Genotype
  • Intercellular Adhesion Molecule-1 (metabolism)
  • Leukocyte Common Antigens (metabolism)
  • Leukocytes (metabolism)
  • Male
  • Membrane Glycoproteins (genetics, metabolism)
  • Mice
  • Mice, Knockout
  • NADPH Oxidase 2
  • NADPH Oxidases (genetics, metabolism)
  • Oxidative Stress (genetics)
  • Peroxynitrous Acid (biosynthesis)
  • Retina (metabolism)
  • Tyrosine (metabolism)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: